APA (7th ed.) Citation

Elliott, J., Klevebro, F., Mantziari, S., Markar, S. R., Goense, L., Johar, A., . . . group, E. s. (2023). 143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY. Diseases of the Esophagus, 36, 1. https://doi.org/10.1093/dote/doad052.024

Chicago Style (17th ed.) Citation

Elliott, Jessie, et al. "143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY." Diseases of the Esophagus 36 (2023): 1. https://doi.org/10.1093/dote/doad052.024.

MLA (9th ed.) Citation

Elliott, Jessie, et al. "143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY." Diseases of the Esophagus, vol. 36, 2023, p. 1, https://doi.org/10.1093/dote/doad052.024.